GENETIC ANALYSIS OF THE UPSTREAM CONTROL OF YEAST RAS

Information

  • Research Project
  • 3299327
  • ApplicationId
    3299327
  • Core Project Number
    R01GM041258
  • Full Project Number
    7R01GM041258-05
  • Serial Number
    41258
  • FOA Number
  • Sub Project Id
  • Project Start Date
    12/1/1988 - 35 years ago
  • Project End Date
    6/30/1995 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    9/10/1992 - 31 years ago
  • Budget End Date
    6/30/1993 - 31 years ago
  • Fiscal Year
    1992
  • Support Year
    5
  • Suffix
  • Award Notice Date
    9/18/1992 - 31 years ago

GENETIC ANALYSIS OF THE UPSTREAM CONTROL OF YEAST RAS

Mutations in ras genes are involved in the pathogenesis of several human tumors, but relatively little is understood about the biochemical function or regulation of ras gene products in normal or tumor cells. In order to gain more insight into the control of the activity of Ras proteins, we propose to continue our search for novel regulators of Ras protein activity in the model eukaryotic cell, Saccharomyces cerevisiae. We will place special emphasis on the identification and characterization of novel positive regulators of Ras activity, by use of a genetic screen that has already identified a new gene required for Ras activation. Novel positive regulators of Ras, as well as the negative regulator we previously identified called Rpil, will be studied in depth by a combination of molecular genetic and biochemical approaches. We will utilize specific biochemical assays of Ras protein activation involving recombinant Cac25 and recombinant Ira2 proteins to explore the possible function of these novel regulators in light of what is already known about proteins that are involved in Ras regulation. Finally, we propose to study the requirement for specific regulators of Ras activity (e.g., Cdc25, Ira1, Ira2, and Rpil) in the transduction of specific nutrient signals to Ras proteins. Our long term goal is to gain a complete molecular picture of the gene products involved in the control of Ras activity and to determine their biochemical mode of action.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    862
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    GEN
  • Study Section Name
    Genetics Study Section
  • Organization Name
    ONYX PHARMACEUTICALS
  • Organization Department
  • Organization DUNS
  • Organization City
    RICHMOND
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94806
  • Organization District
    UNITED STATES